Skip to main content

Temovate Emollient Side Effects

Generic name: clobetasol topical

Medically reviewed by Drugs.com. Last updated on Aug 31, 2023.

Note: This document contains side effect information about clobetasol topical. Some dosage forms listed on this page may not apply to the brand name Temovate Emollient.

Applies to clobetasol topical: topical application cream, topical application emollient cream, topical application foam, topical application gel/jelly, topical application lotion, topical application ointment, topical application shampoo, topical application solution, topical application spray.

Serious side effects of Temovate Emollient

Along with its needed effects, clobetasol topical (the active ingredient contained in Temovate Emollient) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking clobetasol topical:

More common

Less common

Rare

Incidence not known

Other side effects of Temovate Emollient

Some side effects of clobetasol topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to clobetasol topical: compounding powder, topical cream, topical foam, topical gel, topical kit, topical lotion, topical ointment, topical shampoo, topical solution, topical spray.

General

The most common side effect reported was skin discomfort.[Ref]

Endocrine

Postmarketing reports: Cushing's syndrome, adrenal suppression[Ref]

Dermatologic

Common (1% to 10%): Skin discomfort, acne/folliculitis, telangiectasia, skin atrophy, dry skin

Uncommon (0.1% to 1%): Local signs of irritation, pruritus, urticaria

Frequency not reported: Stria, purpura, contact dermatitis, pigmentation changes, pustular eruptions, hypertrichosis, irritant dermatitis

Postmarketing reports: Erythema, alopecia, pain of skin, skin exfoliation, chapped skin, scaling, induration/papulation,

lichenification, psoriasis (aggravation) plaque elevation, excoriation, rash, hair color changes, skin tightness[Ref]

Local

Frequency not reported: Itching[Ref]

Ocular

Common (1% to 10%): Eye stinging/burning

Postmarketing reports: Eye pain, blurred vision, eye irritation[Ref]

Other

Frequency not reported: Edema[Ref]

Gastrointestinal

Postmarketing reports: Nausea[Ref]

Metabolic

Frequency not reported: Hyperglycemia, glucosuria[Ref]

Nervous system

Common (1% to 10%): Headache

Postmarketing reports: Dizziness[Ref]

Frequently asked questions

References

1. "Product Information. Temovate (clobetasol topical)." Glaxo Wellcome

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.